ClinicalTrialsFinder

CD20-positive Non-Hodgkin Lymphoma Clinical Trials in Zhengzhou, Henan

1 recruitingZhengzhou, Henan, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma

CD20-positive Non-Hodgkin Lymphoma
Guangzhou Excelmab Inc.415 enrolled4 locationsNCT06021678